<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>News - Isis Innovation</title>
    <link>http://www.isis-innovation.com/news/index.html</link>
    <description>The latest news from Isis Innovation, technology transfer from the University of Oxford.</description>
    <item>
       <title>Royal Visit to Isis Innovation</title>
       <link>http://www.isis-innovation.com/news/news/RoyalVisittoIsisInnovation.html</link> 
       <description>His Royal Highness The Duke of York visited Isis Innovation in Oxford to learn more about Isis’ successful efforts to commercialise technology that originates from the University of Oxford and other clients.</description>
    </item>
    <item>
       <title>Isis Helps Oxford Company Raise £3m to Commercialise Predictive Cancer Biomarkers</title>
       <link>http://www.isis-innovation.com/news/news/IsisHelpsRaise3mforCancerBiomarkers.html</link> 
       <description>Treating only patients who are likely to benefit from anti-cancer drugs and identifying quickly which treatment is best for each person, is the aim behind new spin-out, Oxford Cancer Biomarkers Ltd.</description>
    </item>
    <item>
       <title>Isis Spin-out Powers "Formula 1 Speed" Electric Car</title>
       <link>http://www.isis-innovation.com/news/news/SpinoutPowersLolaDraysonEV.html</link> 
       <description>The Lola-Drayson B12/69EV, powered by YASA Motors was shown to Minister for Trade and Investment, Lord Green by its co-developer Lord Paul Drayson, the former Minister of Science and Innovation, both of whom were speaking at the MIA Low Carbon Racing Conference.</description>
    </item>
    <item>
       <title>Isis Spin-outs Feature in Latest UK Government Report on Innovation</title>
       <link>http://www.isis-innovation.com/news/IsisSpinoutsinLatestUKGovernmentReport.html</link> 
       <description>Spin-outs from the University of Oxford are showcased in the recent BIS report, ‘Innovation and Research Strategy for Growth’.</description>
    </item>
    <item>
       <title>Oxford Leads Patent League Table</title>
       <link>http://www.isis-innovation.com/news/news/OxfordLeadsPatentLeagueTable.html</link> 
       <description>An analysis of UK patenting has found that the University of Oxford is ranked first amongst UK institutions.</description>
    </item>
    <item>
       <title>Energy Monitoring and Management - a New Service From Oxford Spin-out, Pilio</title>
       <link>http://www.isis-innovation.com/news/news/EnergyMonitoringManagementFromPilio.html</link> 
       <description>The latest spin-out from the University of Oxford, Pilio Limited, provides a cost-effective online tool enabling small and medium businesses to monitor and manage their energy usage, potentially saving up to 40 per cent of their energy budget.</description>
    </item>
    <item>
       <title>Oxford Innovation Society Meeting in Madrid hosted by Isis and Fundación Barrié</title>
       <link>http://www.isis-innovation.com/news/news/IsisFundacionBarrieHostsInnovationEvent.html</link> 
       <description>Isis Innovation and philanthropic investors Fundación Barrié hosted a forum on Spanish innovation and growth at Madrid's Palacio de Fernán Nuñez on Thursday November 3rd.</description>
    </item>
    <item>
       <title>Oxitec, an Oxford University Spin-out, Reports Successful Field Trials</title>
       <link>http://www.isis-innovation.com/news/news/OxitecReportsSuccessfulFieldTrials.html</link>
       <description>Suppression of mosquitos responsible for the spread of dengue has been achieved in trials.</description>
    </item>
    <item>
       <title>Oxford Imaging Detectors Spin-out Improves Scientific Imaging</title>
       <link>http://www.isis-innovation.com/news/news/OxfordDetectorsImprovesScientificImaging.html</link> 
       <description>Oxford Imaging Detectors is developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.</description>
    </item>
    <item>
       <title>Record Number of Attendees at Investor Event</title>
       <link>http://www.isis-innovation.com/news/news/RecordNumberofAttendeesatInvestorsEvent.html</link>
       <description>Over 70 people attended the Isis Angels Network event on 4th October, at which four exciting new ventures were introduced.</description>
    </item>
    <item>
       <title>Isis Spin-out OXEMS to Transform Utility Asset Management</title>
       <link>http://www.isis-innovation.com/news/news/OXEMSTransformsAssetManagement.html</link>
       <description>OXEMS will improve quality assurance, health and safety, and cost for the management of pipelines and other utilities.</description>
    </item>
    <item>
       <title>Isis Welcomes Chinese Vice-Premier for Economic Policy during his visit to Oxford</title>
       <link>http://www.isis-innovation.com/news/news/IsisWelcomesChineseVicePremier.html</link>
       <description>The Chinese Vice-Premier for economic policy, Wang Qishan visited Oxford on Friday 9th September, and heard from a senior executive of Isis Innovation about Oxford's successful Technology Transfer model.</description>
    </item>
    <item>
       <title>Oxford Scanner Reveals Secrets of Documents, Ancient and Modern</title>
       <link>http://www.isis-innovation.com/news/news/OxfordScannerRevealsSecrets.html</link> 
       <description>University of Oxford spin-out originating from the Classics department is set to commercialise a powerful, affordable and portable multispectral scanner.</description>
    </item>
    <item>
       <title>Record Results in Isis 2011 Annual Report</title>
       <link>http://www.isis-innovation.com/news/news/Isis2011RecordResults.html</link> 
       <description>Isis achieved a revenue increase of 12.5% to £8.4m, and returned £4.8m to the University of Oxford and its researchers.</description>
    </item>
    <item>
       <title>New Milestone for TB Drug Development</title>
       <link>http://www.isis-innovation.com/news/news/NewMilestoneforTBDrug.html</link>
       <description>The start of Phase IIb trials of the MVA85A vaccine and related technology, licensed by Isis Innovation to OETC Ltd. in 2008, has been announced.</description>
    </item>
  </channel>
</rss> 
